Filings under VIR by Virco MFG Corporation (CIK 0000751365) from Jan 13, 2006 to Jun 19, 2007 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | More Robert J | Director | Other(J) | 8K | — | $0 |
| Aug 11, 2026 | More Robert J | Director | Other(J) | 8K | — | $0 |
| Jun 9, 2026 | Coughlin Timothy | Director | Grant(A) | 8K | — | $0 |
| Jun 9, 2026 | Coughlin Timothy | Director | Grant(A) | 8K | — | $0 |
| Jun 9, 2026 | Coughlin Timothy | Director | Grant(A) | 16K | — | $0 |
| Jun 9, 2026 | Coughlin Timothy | Director | Grant(A) | 16K | — | $0 |
| Jun 1, 2026 | Sabatini Brent | SVP, Chief Accounting Officer | Sell(S) | 379 | $9.45 | $4K |
| Jun 1, 2026 | Napolitano Janet | Director | Sell(S) | 3K | $9.45 | $30K |
| May 27, 2026 | Sigal Charles Elliott | Director | Grant(A) | 16K | — | $0 |
| May 27, 2026 | Sigal Charles Elliott | Director | Grant(A) | 8K | — | $0 |
| May 27, 2026 | More Robert J | Director | Grant(A) | 16K | — | $0 |
| May 27, 2026 | More Robert J | Director | Grant(A) | 8K | — | $0 |
| May 27, 2026 | Farid Ramy | Director | Grant(A) | 16K | — | $0 |
| May 27, 2026 | Farid Ramy | Director | Grant(A) | 8K | — | $0 |
| May 27, 2026 | Hatfield Jeffrey S. | Director | Grant(A) | 16K | — | $0 |
| May 27, 2026 | Hatfield Jeffrey S. | Director | Grant(A) | 8K | — | $0 |
| May 27, 2026 | Napolitano Janet | Director | Grant(A) | 16K | — | $0 |
| May 27, 2026 | Napolitano Janet | Director | Grant(A) | 8K | — | $0 |
| May 27, 2026 | Bischofberger Norbert W | Director | Grant(A) | 16K | — | $0 |
| May 27, 2026 | Bischofberger Norbert W | Director | Grant(A) | 8K | — | $0 |
| May 1, 2026 | Sato Vicki L | Director | Sell(S) | 22K | $10.05 | $221K |
| Apr 29, 2026 | De Backer Marianne | President and CEO, Director | Other(J) | 234K | — | $0 |
| Apr 29, 2026 | De Backer Marianne | President and CEO, Director | Other(J) | 234K | — | $0 |
| Apr 6, 2026 | De Backer Marianne | President and CEO, Director | Sell(S) | 73K | $9.16 | $664K |
| Apr 1, 2026 | Sato Vicki L | Director | Sell(S) | 22K | $9.07 | $200K |
| Mar 23, 2026 | Sabatini Brent | SVP, Chief Accounting Officer | Sell(S) | 8K | $9.12 | $70K |
| Mar 20, 2026 | O'Byrne Jason | EVP & Chief Financial Officer | Other(J) | 3K | — | $0 |
| Mar 20, 2026 | O'Byrne Jason | EVP & Chief Financial Officer | Other(J) | 3K | — | $0 |
| Mar 2, 2026 | Sato Vicki L | Director | Sell(S) | 200 | $9.98 | $2K |
| Mar 2, 2026 | Sato Vicki L | Director | Sell(S) | 22K | $9.50 | $207K |
| Feb 25, 2026 | de Verneuil Vanina | EVP, General Counsel, Corp Sec | Sell(S) | 14K | $9.82 | $135K |
| Feb 25, 2026 | Eisner Mark | EVP and Chief Medical Officer | Sell(S) | 2K | $9.82 | $19K |
| Feb 24, 2026 | De Backer Marianne | Chief Executive Officer, Director | Sell(S) | 15K | $9.53 | $141K |
| Feb 24, 2026 | de Verneuil Vanina | EVP, General Counsel, Corp Sec | Sell(S) | 3K | $9.53 | $30K |
| Feb 24, 2026 | Eisner Mark | EVP and Chief Medical Officer | Sell(S) | 2K | $9.53 | $15K |
| Feb 24, 2026 | O'Byrne Jason | EVP & Chief Financial Officer | Sell(S) | 2K | $9.53 | $16K |
| Feb 24, 2026 | Sabatini Brent | SVP, Chief Accounting Officer | Sell(S) | 1K | $9.53 | $14K |
| Feb 24, 2026 | Sato Vicki L | Director | Option exercise(M) | 42K | $1.49 | $63K |
| Feb 24, 2026 | Sato Vicki L | Director | Sell(S) | 42K | $9.75 | $411K |
| Feb 24, 2026 | Sato Vicki L | Director | Sell(S) | 200 | $10.26 | $2K |
| Feb 24, 2026 | Sato Vicki L | Director | Option exercise(M) | 42K | — | $0 |
| Feb 23, 2026 | De Backer Marianne | Chief Executive Officer, Director | Sell(S) | 19K | $7.45 | $142K |
| Feb 23, 2026 | de Verneuil Vanina | EVP, General Counsel, Corp Sec | Sell(S) | 4K | $7.45 | $33K |
| Feb 23, 2026 | Eisner Mark | EVP and Chief Medical Officer | Sell(S) | 2K | $7.45 | $16K |
| Feb 23, 2026 | O'Byrne Jason | EVP & Chief Financial Officer | Sell(S) | 2K | $7.45 | $16K |
| Feb 23, 2026 | Sabatini Brent | SVP, Chief Accounting Officer | Sell(S) | 2K | $7.45 | $14K |
| Feb 22, 2026 | De Backer Marianne | Chief Executive Officer, Director | Grant(A) | 285K | — | $0 |
| Feb 22, 2026 | De Backer Marianne | Chief Executive Officer, Director | Grant(A) | 570K | — | $0 |
| Feb 22, 2026 | de Verneuil Vanina | EVP, General Counsel, Corp Sec | Grant(A) | 55K | — | $0 |
| Feb 22, 2026 | de Verneuil Vanina | EVP, General Counsel, Corp Sec | Grant(A) | 110K | — | $0 |
| Feb 22, 2026 | Eisner Mark | EVP and Chief Medical Officer | Grant(A) | 55K | — | $0 |
| Feb 22, 2026 | Eisner Mark | EVP and Chief Medical Officer | Grant(A) | 110K | — | $0 |
| Feb 22, 2026 | O'Byrne Jason | EVP & Chief Financial Officer | Grant(A) | 55K | — | $0 |
| Feb 22, 2026 | O'Byrne Jason | EVP & Chief Financial Officer | Grant(A) | 110K | — | $0 |
| Feb 22, 2026 | Sabatini Brent | SVP, Chief Accounting Officer | Grant(A) | 25K | — | $0 |
| Feb 22, 2026 | Sabatini Brent | SVP, Chief Accounting Officer | Grant(A) | 50K | — | $0 |
| Feb 13, 2026 | Sabatini Brent | SVP, Chief Accounting Officer | Sell(S) | 2K | $7.79 | $12K |
| Feb 2, 2026 | Sato Vicki L | Director | Sell(S) | 22K | $7.71 | $170K |
| Jan 2, 2026 | Sato Vicki L | Director | Sell(S) | 22K | $5.93 | $130K |
| Dec 1, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell(S) | 192K | $5.98 | $1.1M |
| Dec 1, 2025 | Sato Vicki L | Director | Sell(S) | 22K | $6.00 | $132K |
| Nov 28, 2025 | Softbank Vision Fund (Aiv M1) L.P. | 10% Owner | Sell(S) | 61K | $6.44 | $396K |
| Nov 26, 2025 | Softbank Vision Fund (Aiv M1) L.P. | 10% Owner | Sell(S) | 128K | $6.39 | $818K |
| Nov 25, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell(S) | 236K | $6.38 | $1.5M |
| Nov 24, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell(S) | 228K | $6.15 | $1.4M |
| Nov 17, 2025 | O'Byrne Jason | EVP & Chief Financial Officer | Sell(S) | 7K | $5.56 | $38K |
| Nov 5, 2025 | de Verneuil Vanina | EVP, General Counsel, Corp Sec | Sell(S) | 2K | $5.16 | $12K |
| Nov 3, 2025 | Sato Vicki L | Director | Sell(S) | 22K | $5.64 | $124K |
| Nov 3, 2025 | de Verneuil Vanina | EVP and General Counsel | Sell(S) | 1K | $5.86 | $8K |
| Oct 29, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell(S) | 100 | $6.49 | $649 |
| Oct 28, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell(S) | 24K | $6.50 | $159K |
| Oct 27, 2025 | SB Investment Advisers (UK) Ltd | 10% Owner | Sell(S) | 66K | $6.05 | $402K |
| Oct 24, 2025 | SB Investment Advisers (UK) Ltd | 10% Owner | Sell(S) | 47K | $5.96 | $278K |
| Oct 23, 2025 | SB Investment Advisers (UK) Ltd | 10% Owner | Sell(S) | 154K | $5.99 | $925K |
| Oct 22, 2025 | SB Investment Advisers (UK) Ltd | 10% Owner | Sell(S) | 144K | $6.15 | $887K |
| Oct 21, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell(S) | 110K | $6.30 | $691K |
| Oct 20, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell(S) | 221K | $6.20 | $1.4M |
| Oct 16, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell(S) | 13K | $6.10 | $78K |
| Oct 15, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell(S) | 17K | $6.07 | $101K |
| Oct 10, 2025 | Softbank Vision Fund (Aiv M1) L.P. | 10% Owner | Sell(S) | 2K | $6.08 | $14K |
| Oct 9, 2025 | Softbank Vision Fund (Aiv M1) L.P. | 10% Owner | Sell(S) | 249K | $6.14 | $1.5M |
| Oct 8, 2025 | SB Investment Advisers (UK) Ltd | 10% Owner | Sell(S) | 466K | $6.05 | $2.8M |
| Oct 7, 2025 | SB Investment Advisers (UK) Ltd | 10% Owner | Sell(S) | 72K | $5.60 | $404K |
| Oct 6, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell(S) | 74K | $5.69 | $421K |
| Oct 3, 2025 | SVF Endurance (Cayman) Ltd | 10% Owner | Sell(S) | 450K | $5.56 | $2.5M |
| Oct 1, 2025 | Sato Vicki L | Director | Sell(S) | 22K | $5.84 | $128K |
| Sep 2, 2025 | Sato Vicki L | Director | Sell(S) | 22K | $4.99 | $110K |
| Aug 1, 2025 | Sato Vicki L | Director | Sell(S) | 22K | $4.99 | $110K |
| Jul 17, 2025 | Eisner Mark | EVP and Chief Medical Officer | Sell(S) | 4K | $5.47 | $20K |
| Jul 15, 2025 | Eisner Mark | EVP and Chief Medical Officer | Sell(S) | 7K | $5.47 | $37K |
| Jul 1, 2025 | Sato Vicki L | Director | Sell(S) | 22K | $5.10 | $112K |
| Jun 9, 2025 | More Robert J | Director | Other(J) | 14K | — | $0 |
| Jun 9, 2025 | More Robert J | Director | Other(J) | 14K | — | $0 |
| Jun 6, 2025 | Bischofberger Norbert W | Director | Other(J) | 11K | — | $0 |
| Jun 6, 2025 | Bischofberger Norbert W | Director | Other(J) | 11K | — | $0 |
| Jun 2, 2025 | Napolitano Janet | Director | Sell(S) | 3K | $5.05 | $16K |
| May 30, 2025 | Bischofberger Norbert W | Director | Grant(A) | 8K | — | $0 |
| May 30, 2025 | Bischofberger Norbert W | Director | Grant(A) | 16K | — | $0 |
| May 30, 2025 | Farid Ramy | Director | Grant(A) | 8K | — | $0 |
| May 30, 2025 | Farid Ramy | Director | Grant(A) | 16K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Vir Biotechnology, Inc., SEC CIK 0001706431. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under VIR and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-05. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for VIR